Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Hydroxycarbamide Market Research Report 2017

  • QYR2325966
  • 156 Pages
  • December 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
This report studies the Hydroxycarbamide market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Hydroxycarbamide market by product type and applications/end industries.

In the last several years, global market of Hydroxycarbamide developed rapidly, with an average growth rate of 5.72%. In 2016, global revenue of Hydroxycarbamide is nearly 180 M USD; the actual production is about 1760 M Unit.

The major players in global Hydroxycarbamide market include

Bristol Myers Squibb

Taj Pharma

Beijing Jialin Pharma

Qilu Pharmaceutical

Teva Pharma

Cipla

Zydus Cadila

United Biotech

Par Pharma

Khandelwal Laboratories

Alkem (Cytomed)

Samarth Pharma

VHB Life Sciences

Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of Hydroxycarbamide in these regions, from 2012 to 2022 (forecast), covering

North America

Europe

Asia-Pacific

South America

Middle East and Africa

On the basis of product, the Hydroxycarbamide market is primarily split into

Capsule

Tablet

On the basis on the end users/applications, this report covers

Sickle Cell Disease

Cancer

Other

Table of Contents

1 Hydroxycarbamide Market Overview 1

1.1 Product Overview and Scope of Hydroxycarbamide 1

1.2 Hydroxycarbamide Segment by Types 3

1.2.1 Global Hydroxycarbamide Production Market Share (%) by Types in 2016 3

1.2.2 Capsule 4

1.2.3 Tablet 4

1.3 Global Hydroxycarbamide Segment by Applications 5

1.3.1 Global Hydroxycarbamide Consumption Share by Applications 5

1.3.2 Sickle-cell Disease 6

1.3.3 Cancer 6

1.4 Global Hydroxycarbamide Market by Regions (2012-2022) 7

1.4.1 Global Hydroxycarbamide Market Size and Growth Rate Comparison by Regions (2012-2022) 7

1.4.2 North America Hydroxycarbamide Status and Prospect (2012-2022) 8

1.4.3 Europe Hydroxycarbamide Status and Prospect (2012-2022) 9

1.4.4 Asia Pacific Hydroxycarbamide Status and Prospect (2012-2022) 10

1.4.5 South America Hydroxycarbamide Status and Prospect (2012-2022) 11

1.4.6 Middle East and Africa Hydroxycarbamide Status and Prospect (2012-2022) 12

1.5 Global Hydroxycarbamide Market Size (2012-2022) 13

1.5.1 Global Hydroxycarbamide Revenue Status and Outlook (2012-2022) 13

1.5.2 Global Hydroxycarbamide Production Status and Outlook (2012-2022) 14

2 Global Hydroxycarbamide Market Competition by Manufacturers 15

2.1 Global Hydroxycarbamide Production and Share by Manufacturers (2016-2017) 15

2.2 Global Hydroxycarbamide Revenue and Share by Manufacturers (2016-2017) 17

2.3 Global Hydroxycarbamide Average Price by Manufacturers (2016-2017) 19

2.4 Hydroxycarbamide Market Competitive Situation and Trends 21

2.4.1 Hydroxycarbamide Market Concentration Rate 21

2.4.2 Hydroxycarbamide Market Share of Top 3 and Top 5 Manufacturers 22

2.4.3 Mergers & Acquisitions, Expansion 23

3 Global Hydroxycarbamide Production by Regions (2012-2017) 26

3.1 Global Hydroxycarbamide Production and Market Share by Regions (2012-2017) 26

3.2 Global Hydroxycarbamide Revenue and Market Share by Regions (2012-2017) 28

3.3 Global Hydroxycarbamide Production, Revenue, Price and Gross Margin (2012-2017) 30

3.4 North America Hydroxycarbamide Production (2012-2017) 31

3.4.1 North America Hydroxycarbamide Production and Growth Rate (2012-2017) 31

3.4.2 North America Hydroxycarbamide Production, Revenue, Price and Gross Margin (2012-2017) 31

3.5 Europe Hydroxycarbamide Production (2012-2017) 32

3.5.1 Europe Hydroxycarbamide Production and Growth Rate (2012-2017) 32

3.5.2 Europe Hydroxycarbamide Production, Revenue, Price and Gross Margin (2012-2017) 32

3.6 Asia Pacific Hydroxycarbamide Production (2012-2017) 33

3.6.1 Asia Pacific Hydroxycarbamide Production and Growth Rate (2012-2017) 33

3.6.2 Asia Pacific Hydroxycarbamide Production, Revenue, Price and Gross Margin (2012-2017) 34

3.7 South America Hydroxycarbamide Production (2012-2017) 35

3.7.1 South America Hydroxycarbamide Production and Growth Rate (2012-2017) 35

3.7.2 South America Hydroxycarbamide Production, Revenue, Price and Gross Margin (2012-2017) 35

3.8 Middle East and Africa Hydroxycarbamide Production (2012-2017) 36

3.8.1 Middle East and Africa Hydroxycarbamide Production and Growth Rate (2012-2017) 36

3.8.2 Middle East and Africa Hydroxycarbamide Production, Revenue, Price and Gross Margin (2012-2017) 37

4 Global Hydroxycarbamide Consumption by Regions (2012-2017) 38

4.1 Global Hydroxycarbamide Consumption by Regions (2012-2017) 38

4.2 North America Hydroxycarbamide Consumption (2012-2017) 40

4.3 Europe Hydroxycarbamide Consumption (2012-2017) 41

4.4 Asia Pacific Hydroxycarbamide Consumption (2012-2017) 42

4.5 South America Hydroxycarbamide Consumption (2012-2017) 43

4.6 Middle East and Africa Hydroxycarbamide Consumption (2012-2017) 44

5 Global Hydroxycarbamide Production, Revenue (Value), Price Trend by Types 45

5.1 Global Hydroxycarbamide Production and Market Share by Types (2012-2017) 45

5.2 Global Hydroxycarbamide Revenue and Market Share by Types (2012-2017) 47

5.3 Global Hydroxycarbamide Price by Types (2012-2017) 48

5.4 Global Hydroxycarbamide Production Growth Rate by Types (2012-2017) 49

6 Global Hydroxycarbamide Market Analysis by Applications 50

6.1 Global Hydroxycarbamide Consumption and Market Share by Applications (2012-2017) 50

6.2 Global Hydroxycarbamide Consumption Growth Rate by Applications (2012-2017) 52

7 Global Hydroxycarbamide Manufacturers Profiles/Analysis 53

7.1 Bristol Myers Squibb 53

7.1.1 Company Basic Information, Key Products and Sales Area 53

7.1.2 Hydroxycarbamide Product Overview 54

7.1.3 Bristol Myers Squibb Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 54

7.2 Taj Pharma 55

7.2.1 Company Basic Information, Key Products and Sales Area 55

7.2.2 Hydroxycarbamide Product Overview 56

7.2.3 Taj Pharma Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 56

7.3 Beijing Jialin Pharma 57

7.3.1 Company Basic Information, Key Products and Sales Area 57

7.3.2 Hydroxycarbamide Product Overview 58

7.3.3 Beijing Jialin Pharma Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 58

7.4 Qilu Pharmaceutical 59

7.4.1 Company Basic Information, Key Products and Sales Area 59

7.4.2 Hydroxycarbamide Product Overview 60

7.4.3 Qilu Pharmaceutical Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 60

7.5 Teva Pharma 61

7.5.1 Company Basic Information, Key Products and Sales Area 61

7.5.2 Hydroxycarbamide Product Overview 62

7.5.3 Teva Pharma Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 62

7.6 Cipla 63

7.6.1 Company Basic Information, Key Products and Sales Area 63

7.6.2 Hydroxycarbamide Product Overview 64

7.6.3 Cipla Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 64

7.7 Zydus Cadila 65

7.7.1 Company Basic Information, Key Products and Sales Area 65

7.7.2 Hydroxycarbamide Product Overview 66

7.7.3 Zydus Cadila Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 66

7.8 United Biotech 67

7.8.1 Company Basic Information, Key Products and Sales Area 67

7.8.2 Hydroxycarbamide Product Overview 68

7.8.3 United Biotech Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 68

7.9 Par Pharma 69

7.9.1 Company Basic Information, Key Products and Sales Area 69

7.9.2 Hydroxycarbamide Product Overview 70

7.9.3 Par Pharma Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 71

7.10 Khandelwal Laboratories 71

7.10.1 Company Basic Information, Key Products and Sales Area 71

7.10.2 Hydroxycarbamide Product Overview 72

7.10.3 Khandelwal Laboratories Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 73

7.11 Alkem (Cytomed) 73

7.11.1 Company Basic Information, Key Products and Sales Area 73

7.11.2 Hydroxycarbamide Product Overview 74

7.11.3 Alkem (Cytomed) Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 75

7.12 Samarth Pharma 75

7.12.1 Company Basic Information, Key Products and Sales Area 75

7.12.2 Hydroxycarbamide Product Overview 76

7.12.3 Samarth Pharma Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 76

7.13 VHB Life Sciences 77

7.13.1 Company Basic Information, Key Products and Sales Area 77

7.13.2 Hydroxycarbamide Product Overview 78

7.13.3 VHB Life Sciences Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 78

8 Hydroxycarbamide Manufacturing Cost Analysis 79

8.1 Hydroxycarbamide R&D Cost Analysis 79

8.1.1 Clinical Phase Costs 80

8.1.2 Capitalized Costs 81

8.2 Proportion of Manufacturing Cost Structure 82

8.2.1 Raw Materials 82

8.2.2 Labor Cost 83

8.2.2.1 USA Labor Cost Analysis 84

8.2.2.2 Europe Labor Costs Analysis 86

8.2.2.3 Asia Labor Costs Analysis 88

8.2.3 Other Costs Analysis 90

8.2.3.1 USA Other Cost Analysis 90

8.2.3.2 Europe Other Cost Analysis 91

8.2.3.3 China Other Cost Analysis 92

8.3 Manufacturing Process Analysis of Hydroxycarbamide 94

9 Industrial Chain, Sourcing Strategy and Downstream Buyers 95

9.1 Hydroxycarbamide Industrial Chain Analysis 95

9.2 Upstream Raw Materials Sourcing 95

9.3 Downstream Buyers 96

10 Marketing Strategy Analysis, Distributors/Traders 97

10.1 Marketing Channel 97

10.1.1 Direct Marketing 97

10.1.2 Indirect Marketing 98

10.1.3 Marketing Channel Development Trend 98

10.2 Market Positioning 98

10.2.1 Pricing Strategy 98

10.2.2 Brand Strategy 99

10.2.2.1 Introducing Pharmaceutical Branding Strategies 99

10.2.2.2 Building Pharmaceutical Brands 100

10.2.2.3 Communicating Pharmaceutical Brands 101

10.2.2.4 Alternative Brand Models 101

10.2.2.5 The Future of Pharmaceutical Branding 102

10.3 Distributors/Traders List 103

11 Market Effect Factors Analysis 104

11.1 Technology Progress/Risk 104

11.1.1 Substitutes Threat 104

11.1.2 Technology Progress in Related Industry 104

11.2 Consumer Needs/Customer Preference Change 104

11.3 Economic/Political Environmental Change 105

12 Global Hydroxycarbamide Market Forecast (2017-2022) 114

12.1 Global Hydroxycarbamide Production, Revenue Forecast (2017-2022) 114

12.1.1 Global Hydroxycarbamide Production (M Unit) and Growth Rate (%) Forecast (2017-2022) 114

12.1.2 Global Hydroxycarbamide Revenue (M USD) and Growth Rate (%) Forecast (2017-2022) 115

12.1.3 Global Hydroxycarbamide Price and Trend Forecast (2017-2022) 116

12.2 Global Hydroxycarbamide Production (M Unit) Forecast by Regions (2017-2022) 116

12.2.1 North America Hydroxycarbamide Production (M Unit) and Revenue (M USD) Forecast (2017-2022) 117

12.2.2 Europe Hydroxycarbamide Production (M Unit), Revenue (M USD) Forecast (2017-2022) 119

12.2.3 Asia-Pacific Hydroxycarbamide Production (M Unit), Revenue (M USD) Forecast (2017-2022) 121

12.2.4 South America Hydroxycarbamide Production (M Unit), Revenue (M USD) Forecast (2017-2022) 123

12.2.5 Middle East and Africa Hydroxycarbamide Production (M Unit), Revenue (M USD) Forecast (2017-2022) 125

12.3 Global Hydroxycarbamide Consumption (M Unit) Forecast by Regions (2017-2022) 126

12.3.1 North America Hydroxycarbamide Consumption (M Unit) Forecast (2017-2022) 128

12.3.2 Europe Hydroxycarbamide Consumption (M Unit) Forecast (2017-2022) 129

12.3.3 Asia-Pacific Hydroxycarbamide Consumption (M Unit) Forecast (2017-2022) 130

12.3.4 South America Hydroxycarbamide Consumption (M Unit) Forecast (2017-2022) 131

12.3.5 Middle East and Africa Hydroxycarbamide Consumption (M Unit) Forecast (2017-2022) 132

12.4 Global Hydroxycarbamide Production, Revenue and Price Forecast by Type (2017-2022) 132

12.5 Global Hydroxycarbamide Consumption Forecast by Application (2017-2022) 133

13 Research Findings and Conclusion 135

14 Methodology and Data Source 136

14.1 Methodology/Research Approach 136

14.1.1 Research Programs/Design 136

14.1.2 Market Size Estimation 137

14.2 Data Source 139

14.2.1 Secondary Sources 139

14.2.2 Primary Sources 140

14.3 Disclaimer 141

14.4 Author List 142

List of Tables and Figures

Figure Product Picture of Hydroxycarbamide 1

Table Hydroxycarbamide Product Specification 1

Figure Global Hydroxycarbamide Production Market Share (%) by Types in 2016 3

Figure Product Picture of Capsule 4

Figure Product Picture of Tablet 4

Figure Global Hydroxycarbamide Consumption (M Unit) Market Share (%) by Applications in 2016 5

Figure Sickle-cell Disease Examples 6

Figure Cancer Examples 6

Figure Global Hydroxycarbamide Market Size (M USD) Comparison and Growth Rate by Regions (2012-2022) 7

Figure North America Hydroxycarbamide Revenue (M USD) and Growth Rate (2012-2022) 8

Figure Europe Hydroxycarbamide Revenue (M USD) and Growth Rate (2012-2022) 9

Figure Asia Pacific Hydroxycarbamide Revenue (M USD) and Growth Rate (2012-2022) 10

Figure South America Hydroxycarbamide Revenue (M USD) and Growth Rate (2012-2022) 11

Figure Middle East and Africa Hydroxycarbamide Revenue (M USD) and Growth Rate (2012-2022) 12

Figure Global Hydroxycarbamide Revenue (M USD) Status and Outlook (2012-2022) 13

Figure Global Hydroxycarbamide Production (M Unit) Status and Outlook (2012-2022) 14

Table Global Hydroxycarbamide Production (M Unit) of Key Manufacturers (2016-2017) 15

Table Global Hydroxycarbamide Production Market Share by Manufacturers (2016-2017) 15

Figure 2016 Hydroxycarbamide Production Market Share by Manufacturers 16

Figure 2017 Hydroxycarbamide Production Market Share by Manufacturers 17

Table Global Hydroxycarbamide Revenue (M USD) by Manufacturers (2016-2017) 17

Table Global Hydroxycarbamide Revenue Share by Manufacturers (2016-2017) 18

Figure 2016 Global Hydroxycarbamide Revenue Share by Manufacturers 18

Figure 2017 Global Hydroxycarbamide Revenue Share by Manufacturers 19

Table Global Market Hydroxycarbamide Average Price (USD/K Unit) of Key Manufacturers (2016-2017) 19

Figure Global Market Hydroxycarbamide Average Price (USD/K Unit) of Key Manufacturers in 2016 20

Figure 2016 Hydroxycarbamide Production Market Share by Manufacturers 21

Figure Hydroxycarbamide Revenue Market Share of Top 3 Manufacturers in 2016 22

Figure Hydroxycarbamide Revenue Market Share of Top 5 Manufacturers in 2016 23

Table Global Hydroxycarbamide Production (M Unit) by Regions (2012-2017) 26

Table Global Hydroxycarbamide Production Market Share by Regions (2012-2017) 26

Figure Global Hydroxycarbamide Production Market Share by Regions (2012-2017) 27

Figure 2016 Global Hydroxycarbamide Production Market Share by Regions 27

Table Global Hydroxycarbamide Revenue (M USD) by Regions (2012-2017) 28

Table Global Hydroxycarbamide Revenue Market Share by Regions (2012-2017) 28

Figure Global Hydroxycarbamide Revenue Market Share by Regions (2012-2017) 29

Figure 2016 Global Hydroxycarbamide Revenue Market Share by Regions 29

Figure Global Hydroxycarbamide Production (M Unit) and Growth Rate (2012-2017) 30

Table Global Hydroxycarbamide Production (M Unit), Revenue (M USD), Price (USD/K Unit) and Gross Margin (2012-2017) 30

Figure North America Hydroxycarbamide Production (M Unit) and Growth Rate (2012-2017) 31

Table North America Hydroxycarbamide Production (M Unit), Revenue (M USD), Price (USD/K Unit) and Gross Margin (2012-2017) 31

Figure Europe Hydroxycarbamide Production (M Unit) and Growth Rate (2012-2017) 32

Table Europe Hydroxycarbamide Production (M Unit), Revenue (M USD), Price (USD/K Unit) and Gross Margin (2012-2017) 32

Figure Asia Pacific Hydroxycarbamide Production (M Unit) and Growth Rate (2012-2017) 33

Table Asia Pacific Hydroxycarbamide Production (M Unit), Revenue (M USD), Price (USD/K Unit) and Gross Margin (2012-2017) 34

Figure South America Hydroxycarbamide Production (M Unit) and Growth Rate (2012-2017) 35

Table South America Hydroxycarbamide Production (M Unit), Revenue (M USD), Price (USD/K Unit) and Gross Margin (2012-2017) 35

Figure Middle East and Africa Hydroxycarbamide Production (M Unit) and Growth Rate (2012-2017) 36

Table Middle East and Africa Hydroxycarbamide Production (M Unit), Revenue (M USD), Price (USD/K Unit) and Gross Margin (2012-2017) 37

Table Global Hydroxycarbamide Consumption (M Unit) Market by Regions (2012-2017) 38

Table Global Hydroxycarbamide Consumption Market Share by Regions (2012-2017) 38

Figure Global Hydroxycarbamide Consumption Market Share by Regions (2012-2017) 39

Figure 2016 Global Hydroxycarbamide Consumption Market Share by Regions 39

Figure North America Hydroxycarbamide Consumption (M Unit) and Growth Rate (2012-2017) 40

Figure Europe Hydroxycarbamide Consumption (M Unit) and Growth Rate (2012-2017) 41

Figure Asia Pacific Hydroxycarbamide Consumption (M Unit) and Growth Rate (2012-2017) 42

Figure South America Hydroxycarbamide Consumption (M Unit) and Growth Rate (2012-2017) 43

Figure Middle East and Africa Hydroxycarbamide Consumption (M Unit) and Growth Rate (2012-2017) 44

Table Global Hydroxycarbamide Production (M Unit) by Types (2012-2017) 45

Table Global Hydroxycarbamide Production Market Share by Types (2012-2017) 45

Figure Production Market Share of Hydroxycarbamide by Types (2012-2017) 46

Figure 2016 Production Market Share of Hydroxycarbamide by Types 46

Table Global Hydroxycarbamide Revenue (M USD) by Types (2012-2017) 47

Table Global Hydroxycarbamide Revenue Share by Types (2012-2017) 47

Figure Revenue Share of Hydroxycarbamide by Types (2012-2017) 47

Figure 2016 Revenue Market Share of Hydroxycarbamide by Types 48

Table Global Hydroxycarbamide Price (USD/K Unit) by Types (2012-2017) 48

Figure Global Hydroxycarbamide Production Growth Rate by Types (2012-2017) 49

Table Global Hydroxycarbamide Consumption (M Unit) by Applications (2012-2017) 50

Table Global Hydroxycarbamide Consumption Market Share by Applications (2012-2017) 50

Figure Global Hydroxycarbamide Consumption Market Share by Applications (2012-2017) 51

Figure Global Hydroxycarbamide Consumption Market Share by Applications in 2016 51

Figure Global Hydroxycarbamide Consumption Growth Rate by Applications (2012-2017) 52

Table Bristol Myers Squibb Basic Information, Key Products and Sales Area 53

Figure Hydroxycarbamide Product Overview 54

Table Bristol Myers Squibb Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 54

Table Taj Pharma Basic Information, Key Products and Sales Area 55

Figure Hydroxycarbamide Product Overview 56

Table Taj Pharma Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 56

Table Beijing Jialin Pharma Basic Information, Key Products and Sales Area 57

Figure Hydroxycarbamide Product Overview 58

Table Beijing Jialin Pharma Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 58

Table Qilu Pharmaceutical Basic Information, Key Products and Sales Area 59

Figure Hydroxycarbamide Product Overview 60

Table Qilu Pharmaceutical Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 60

Table Teva Pharma Basic Information, Key Products and Sales Area 61

Figure Hydroxycarbamide Product Overview 62

Table Teva Pharma Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 62

Table Cipla Basic Information, Key Products and Sales Area 63

Figure Hydroxycarbamide Product Overview 64

Table Cipla Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 64

Table Zydus Cadila Basic Information, Key Products and Sales Area 65

Figure Hydroxycarbamide Product Overview 66

Table Zydus Cadila Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 66

Table United Biotech Basic Information, Key Products and Sales Area 67

Figure Hydroxycarbamide Product Overview 68

Table United Biotech Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 68

Table Par Pharma Basic Information, Key Products and Sales Area 69

Figure Hydroxycarbamide Product Overview 70

Table Par Pharma Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 71

Table Khandelwal Laboratories Basic Information, Key Products and Sales Area 71

Figure Hydroxycarbamide Product Overview 72

Table Khandelwal Laboratories Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 73

Table Alkem (Cytomed) Basic Information, Key Products and Sales Area 73

Table Hydroxycarbamide Product Overview 74

Table Alkem (Cytomed) Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 75

Table Samarth Pharma Basic Information, Key Products and Sales Area 75

Table Hydroxycarbamide Product Overview 76

Table Samarth Pharma Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 76

Table VHB Life Sciences Basic Information, Key Products and Sales Area 77

Table Hydroxycarbamide Product Overview 78

Table VHB Life Sciences Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 78

Figure Typical Phases from Research to the Market for a Drug Candidate 80

Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Hydroxycarbamide Compound 81

Table Capitalized Preclinical and Clinical Period Costs per Investigational Hydroxycarbamide Compound 82

Table Manufacturing Cost Structure of Hydroxycarbamide 82

Figure Assessment of API Manufacturing Cost By Region 83

Figure USA Overview of Average Hourly Wages 2015-2016 (USD/Hour) 84

Figure USA Overview of Labor Costs 2013-2016 (110 Index Points) 84

Figure Cost of Employing a Factory Worker 86

Figure 2015 Estimated Labor Costs for the Whole Economy in Europe 87

Figure Monthly Minimum Wages in Asia 2016 88

Figure China Overview of Average Yearly Wages 2015-2016 (CNY/Year) 89

Figure Japan Overview of Average Monthly Wages 2015-2016(JPY Thousand/Month) 89

Table Average Price of Electricity to Ultimate Customers 90

Figure Electricity Prices for Household Consumers in 2015 91

Figure Summary of the Driving Assumptions 92

Figure Industrial Electric Rates 2015 (PER KWH) 93

Figure Manufacturing Process Analysis of Hydroxycarbamide 94

Figure Hydroxycarbamide Industrial Chain Analysis 95

Figure Marketing Channel 97

Table Distributors/Traders List 103

Figure Global GDP Growth Rate for 2015 105

Figure US GDP 2006-2016 (Billion USD) 106

Figure US CPI Change 2016-2017 107

Figure EU GDP 2006-2016 (Billion USD) 107

Figure EU CPI Change 2012-2016 108

Figure Germany GDP 2006-2016 (Billion USD) 108

Figure Germany CPI Change 2016-2017 109

Figure UK GDP 2006-2016 (Billion USD) 109

Figure UK CPI Change 2016-2017 110

Figure Italy GDP 2006-2016 (Billion USD) 110

Figure Italy CPI Change 2016-2017 111

Figure Japan GDP 2006-2016 (Billion USD) 111

Figure Japan CPI Change 2012-2016 112

Figure China GDP 2006-2016 (Billion USD) 112

Figure China CPI Change 2016-2017 113

Figure Global Hydroxycarbamide Production (M Unit) and Growth Rate (%) Forecast (2017-2022) 114

Figure Global Hydroxycarbamide Revenue (M USD) and Growth Rate (%) Forecast (2017-2022) 115

Figure Global Hydroxycarbamide Price and Trend Forecast (2017-2022) 116

Table Global Hydroxycarbamide Production (M Unit) Forecast by Regions (2017-2022) 116

Table Global Hydroxycarbamide Revenue (M USD) Forecast by Regions (2017-2022) 117

Figure North America Hydroxycarbamide Production (M Unit) and Growth Rate (%) Forecast (2017-2022) 117

Figure North America Hydroxycarbamide Revenue (M USD) and Growth Rate (%) Forecast (2017-2022) 118

Figure Europe Hydroxycarbamide Production (M Unit) and Growth Rate Forecast (2017-2022) 119

Figure Europe Hydroxycarbamide Revenue (M USD) and Growth Rate (%) Forecast (2017-2022) 120

Figure Asia-Pacific Hydroxycarbamide Production (M Unit) and Growth Rate (%) Forecast (2017-2022) 121

Figure Asia-Pacific Hydroxycarbamide Revenue (M USD) and Growth Rate (%) Forecast (2017-2022) 122

Figure South America Hydroxycarbamide Production (M Unit) and Growth Rate (%) Forecast (2017-2022) 123

Figure South America Hydroxycarbamide Revenue (M USD) and Growth Rate (%) Forecast (2017-2022) 124

Figure Middle East and Africa Hydroxycarbamide Production (M Unit) and Growth Rate (%) Forecast (2017-2022) 125

Figure Middle East and Africa Hydroxycarbamide Revenue (M USD) and Growth Rate (%) Forecast (2017-2022) 126

Table Global Hydroxycarbamide Consumption (M Unit) Forecast by Regions (2017-2022) 126

Figure Global Hydroxycarbamide Consumption Market Share (%) Forecast by Regions (2017-2022) 127

Figure North America Hydroxycarbamide Consumption (M Unit) and Growth Rate (%) Forecast (2017-2022) 128

Figure Europe Hydroxycarbamide Consumption (M Unit) and Growth Rate (%) Forecast (2017-2022) 129

Figure Asia-Pacific Hydroxycarbamide Consumption (M Unit) and Growth Rate (%) Forecast (2017-2022) 130

Figure South America Hydroxycarbamide Consumption (M Unit) and Growth Rate (%) Forecast (2017-2022) 131

Figure Middle East and Africa Hydroxycarbamide Consumption (M Unit) and Growth Rate (%) Forecast (2017-2022) 132

Table Global Hydroxycarbamide Production (M Unit) Forecast by Type (2017-2022) 132

Figure Global Hydroxycarbamide Production Forecast by Type (2017-2022) 132

Table Global Hydroxycarbamide Revenue (M USD) Forecast by Type (2017-2022) 133

Table Global Hydroxycarbamide Revenue Market Share (%) Forecast by Type (2017-2022) 133

Table Global Hydroxycarbamide Price (USD/K Unit) Forecast by Type (2017-2022) 133

Table Global Hydroxycarbamide Consumption (M Unit) Forecast by Application (2017-2022) 133

Figure Global Hydroxycarbamide Consumption Forecast by Application (2017-2022) 134

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370